Clinical Trials Browser

OTHER_GOV × Recurrence × ledipasvir × Clear all

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Phase 4 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic